A long-surviving patient with unresectable advanced gastric cancer responding to S-1 after receiving improved gastrojejunostomy

International Journal of Clinical Oncology

Volumn 9, Issue 3, 2004, Pages 193-196

  Mimatsu, Kenji ^a   Oida, Takatsugu ^a   Kuboi, Youichi ^a   Kawasaki, Atsushi ^a   Kanou, Hisao ^a   Kaneda, Hide ^a   Amano, Sadao ^b  

^a Yokohama Central Hospital   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Improved gastrojejunostomy; S 1; Unresectable gastric cancer

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEATH; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROJEJUNOSTOMY; HUMAN; INOPERABLE CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; PYLORUS STENOSIS; QUALITY OF LIFE; STOMACH CANCER; STOMACH RADIOGRAPHY; VAGINA BLEEDING;

EID: 3142624518     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-004-0387-3     Document Type: Article

References (14)

1. Glimelius B, Hoffman K, Haglund O, et al. (1994) Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol 5:189-190
2. Koizumi W, Kurihara M, Nakano S (2000) Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. Oncology 58:191-197
3. Kwok SPY, Chung SCS, Griffin SM, et al. (1991) Devine exclusion for unresectable carcinoma of the stomach. Br J Surg 78:684-685
4. Schantz SP, Schickler W, Evans TK, et al. (1984) Palliative gastrojejunostomy for pancreatic cancer. Am J Surg 147:793-796
5. Doberneck RC, Berndt GA (1987) Delayed gastric emptying after palliative gastrojejunostomy for cancer of the pancreas. Arch Surg 122:827-829
6. Oya G (1986) Surgical management of the advanced gastric cancer with passage trouble (in Japanese). Gastroenterol Surg 9:1729-1734
7. Kaminishi M, Yamaguchi H, Shimizu N, et al. (1997) Stomach-partitioning gastrojejunostomy for unresectable gastric carcinoma. Arch Surg 132:184-187
8. Devine HB (1925) Basic principles and supreme difficulties in gastric surgery. Surg Gynecol Obstet 40:1-16
9. Lucas CE, Ledgerwood AM, Saxe JM, et al. (1994) A safe and effective bypass for unresectable pancreas cancer. Arch Surg 129:795-799
10. Kajitani T (1992) Gastrojejunostomy at the site of a wedge resection on the greater curvature for an inoperable antral cancer. In: Kajitani T, (ed) Kajitani's surgical atlas of the gastrointestinal tract cancer. Kanehara, Tokyo, pp 64-69
11. Ackerman NB (1985) Gastric and intestinal bypass procedure for obesity. In: Fromm D (ed) Gastrointestinal surgery. Churchill Livingstone, New York, pp 475-518
12. Ota K, Taguchi T, Kimura K (1988) Report on nationwide pooled data and cohort investigation in UFT phase II study. Cancer Chemother Pharmacol 16:333-338
13. Niitani H, Kimura K, Saito T, et al. (1985) Phase II study of 5′-dexo-5-fluorouridine (5′-DFUR) on patients with malignant cancer: multi-institutional cooperative study. Jpn J Cancer Chemother 12:2044-2051
14. Yanagisawa O, Teruya M, Kobayashi K, et al. (2002) A case in which TS-1, an orally administered 5-FU chemotherapeutic agent, showed marked effectiveness against scirrhous type gastric cancer with multiple organ metastases. Jpn J Cancer Chemother 29:761-764